Rafferty Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,394,415
| Closed | -$3.89M | – | 1180 |
|
|
2022
Q4 | $3.89M | Buy |
4,394,415
+1,399,741
| +47% | +$1.24M | 0.03% | 431 |
|
|
2022
Q3 | $4.7M | Buy |
2,994,674
+1,243,608
| +71% | +$1.95M | 0.05% | 345 |
|
|
2022
Q2 | $3.52M | Sell |
1,751,066
-719,616
| -29% | -$1.45M | 0.03% | 354 |
|
|
2022
Q1 | $5.76M | Buy |
2,470,682
+1,620,162
| +190% | +$3.78M | 0.03% | 349 |
|
|
2021
Q4 | $3.96M | Buy |
850,520
+457,080
| +116% | +$2.13M | 0.02% | 467 |
|
|
2021
Q3 | $3M | Buy |
393,440
+99,357
| +34% | +$758K | 0.02% | 478 |
|
|
2021
Q2 | $2.85M | Sell |
294,083
-30,980
| -10% | -$300K | 0.02% | 521 |
|
|
2021
Q1 | $2.69M | Buy |
325,063
+206,611
| +174% | +$1.71M | 0.02% | 548 |
|
|
2020
Q4 | $808K | Sell |
118,452
-195,498
| -62% | -$1.33M | 0.01% | 568 |
|
|
2020
Q3 | $3.5M | Buy |
313,950
+193,048
| +160% | +$2.15M | 0.04% | 242 |
|
|
2020
Q2 | $759K | Buy |
+120,902
| New | +$759K | 0.01% | 616 |
|